You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Etoposide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for etoposide and what is the scope of freedom to operate?

Etoposide is the generic ingredient in four branded drugs marketed by Mylan, Strides Pharma, Accord Hlthcare, Dash Pharms, Dash Pharms Natco, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Pierre Fabre, Teva Parenteral, Teva Pharms Usa, Watson Labs, Watson Labs Inc, Corden Pharma, Bristol Myers Squibb, and Cheplapharm, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for etoposide. Five suppliers are listed for this compound.

Drug Prices for etoposide

See drug prices for etoposide

Recent Clinical Trials for etoposide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fujian Cancer HospitalPhase 2
Hirva MamdaniPhase 2
Biotheus Inc.Phase 2/Phase 3

See all etoposide clinical trials

Pharmacology for etoposide
Drug ClassTopoisomerase Inhibitor
Mechanism of ActionTopoisomerase Inhibitors
Medical Subject Heading (MeSH) Categories for etoposide

US Patents and Regulatory Information for etoposide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb ETOPOPHOS PRESERVATIVE FREE etoposide phosphate INJECTABLE;INJECTION 020906-002 Feb 27, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Dash Pharms Natco ETOPOSIDE etoposide INJECTABLE;INJECTION 203507-001 Nov 20, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bristol Myers Squibb ETOPOPHOS PRESERVATIVE FREE etoposide phosphate INJECTABLE;INJECTION 020906-001 Feb 27, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-002 Dec 30, 1986 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-001 Dec 30, 1986 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Dash Pharms ETOPOSIDE etoposide INJECTABLE;INJECTION 204927-001 Oct 31, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for etoposide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-001 Dec 30, 1986 ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-002 Dec 30, 1986 ⤷  Try a Trial ⤷  Try a Trial
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.